-+ 0.00%
-+ 0.00%
-+ 0.00%

Is Veeva Systems (VEEV) Cheap, Or Is Its Cash Flow Priced In?

Simply Wall St·11/19/2026 22:09:10
Listen to the news

Veeva Systems has had a mixed share price run, with solid gains over several years alongside more recent pullbacks. That puts the focus squarely on what investors are paying for its underlying cash flows. With the stock recently closing at US$277.20, the key issue for you is whether that price lines up with what the business can reasonably generate in cash over time.

  • Over the past 3 years, Veeva Systems has delivered a share price gain of 57.8%, which makes it important to test whether that kind of outcome is grounded in the company’s cash generation rather than sentiment alone.
  • The business model relies heavily on software subscriptions and related services for life sciences clients, which can support recurring revenue and steadier cash inflows that matter a lot when you value the stock using its future cash flows.
  • If you'd rather focus on earnings, this one's for you. See why Veeva Systems's 44.2x P/E tells a different valuation story.

The stock's next move may depend on whether the current US$277.20 price is adequately explained by Veeva Systems' projected cash flows when compared with its intrinsic value estimate from the Discounted Cash Flow (DCF) model.

If you want a broader yardstick for Veeva Systems and its cash flow story, compare it with other potential opportunities screened as 35 high quality undervalued stocks.

Is Veeva Systems Still Cheap on Cash Flow?

The Discounted Cash Flow (DCF) approach values Veeva Systems by projecting the cash it could generate for shareholders and adjusting that back to today. On the latest numbers, the business produced around $1.64b of free cash flow over the last twelve months, so this is not an early-stage story that relies on distant hopes. The model assumes those cash flows keep growing over time rather than shrinking, which fits a subscription driven software model where renewals and add ons can support a steady pipeline.

Analyst forecasts in the DCF include higher free cash flow by 2031, with growth tapering in later years so the curve resembles that of a maturing franchise rather than a hyper growth venture. When those projected cash streams are discounted back and compared with the current US$277.20 share price, the DCF output sits modestly above where the stock trades today, which is what the detailed valuation summary is built to show. Find out what Veeva Systems could be worth using our Discounted Cash Flow (DCF) estimate.

The Veeva Systems Narrative: What Would Justify Today's Price?

Narratives for Veeva Systems pick up where that cash flow puzzle leaves off, by spelling out which paths for growth, profitability and earnings would need to play out for the stock to look materially higher or lower than today’s price. These narratives sit on Simply Wall St’s Community page. Each narrative links its number to a specific view on how Veeva Systems' expansion, margins and risk profile could evolve, giving you a reference point you can revisit as fresh information arrives.

Veeva Systems splits opinion, with one view seeing unusually durable cash flows and another arguing the current price leaves little room for execution slip ups.

Bull case: 28% undervalued

According to John_Eric, a Simply Wall St Community investor, the core appeal of Veeva Systems starts with where its software sits in drug development.

"Drug companies operate in an environment where data integrity, audit trails, controlled workflows, documentation, and regulatory compliance are essential. Moving systems is not simply an IT project..."

Discover why this Narrative puts Veeva Systems at 28% undervalued.

Bear case: 13% overvalued

The bearish analyst Narrative on Simply Wall St frames Veeva Systems as a high quality business already priced for very strong execution.

"The numbers indicate that Veeva Systems' share price already reflects revenue growth that is higher than the mid teens pace described for fiscal 2027..."

Explore why this Narrative puts Veeva Systems at 13% overvalued.

The unanswered question for Veeva Systems

Valuation work only tells part of the Veeva Systems story, and the research here also flags specific concerns that a careful shareholder would want to weigh for themselves. Take a closer look at 1 warning sign before settling on a valuation.